
Braintechsp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
BrainTech develops complete EEG and BCI systems for science, education and industry. Its products include the Perun-32 and Perun-8 amplifiers, the BCI Lab and Blinker devices, and the Perun Headset set. The company also provides software and systems for teaching labs, EEG/BCI research, the PISAK communication system, and the SVAROG bioelectric signal viewer.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2012-07-03. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 1, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282 | Prezydent Miasta Stołecznego Warszawy | |
| Dec 30, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $110,506 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Dec 30, 2019 | Aid for SMEs for innovation support | $22,001 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2019-04-16 | Rozwój przedsiębiorstwa BrainTech Sp. z o.o. poprzez opracowanie nowego projektu wzorniczego bezprzewodowego headsetu EEG. | $124,006 | Program Operacyjny Inteligentny Rozwój | |
| 2016-01-01 | Interfejs mózg-komputer | $756,540 | Program Operacyjny Inteligentny Rozwój |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Piotr Jerzy Durka (62) | 792 | $106,969.21 | 66.5546% |
Marek Kruszyński (38) | 170 | $22,960.56 | 14.2857% |
Maciej Pawlisz (40) | 228 | $30,794.17 | 19.1597% |
Beneficial owners
| Person | Rights |
|---|---|
Piotr Jerzy Durka (62) | Shareholder of a limited liability company, 396000.0 PLN |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Uhura Bionicssp. z o.o. | $88,274.48 | uhura.pl | |
| Hepharmsp. z o.o. | $2,450.87 | hepharm.pl |
Change history
| Date | Event |
|---|---|
| 2019-12-10 | Address change (Jeziorna 23, 02-911, Warszawa → Ul. Puławska 12/3, 02-566, Warszawa) |
| 2018-12-05 | Share capital change (63,000.00 PLN → 595,000.00 PLN) |
| 2017-10-06 | Share capital change (50,000.00 PLN → 63,000.00 PLN) |
| 2017-06-08 | PKD change (Removed: 72, 88; Added: 72.19.Z) |
| 2012-05-28 | Entered in the register |
FAQ
Last updated: 2026-04-23

